Skip to main content

Table 3 Platelet decrement during treatment

From: Impact of different anti-HCV regimens on platelet count during treatment in Egyptian patients

Platelet count decrements All studied patients Group 1
Triple
Group 2
SOF/RBV
Group 3
SIM/SOF
No. % No. % No. % No. %
2 Weeks          
 Decrease 128 76.2% 50 89.3% 34 61.8% 44 77.2%
 No decrease 40 23.8% 6 10.7% 21 38.2% 13 22.8%
4 Weeks          
 Decrease 120 71.4% 46 82.1% 26 47.3% 48 84.2%
 No decrease 48 28.6% 10 17.9% 29 52.7% 9 15.8%
End of treatment         
 Decrease 91 54.8% 41 73.2% 16 29.1% 34 61.8%
 No decrease 75 45.2% 15 26.8% 39 70.9% 21 38.2%
  1. Least decrement% was observed in SOF/RBV